Search

Author/Creator Greos, Leon S

1. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Issue 10209 (2nd November 2019)

Authors:
Bachert, Claus; Han, Joseph K; Desrosiers, Martin; Hellings, Peter W; Amin, Nikhil; Lee, Stella E; Mullol, Joaquim; Greos, Leon S; Bosso, John V; Laidlaw, Tanya M; Cervin, Anders U; Maspero, Jorge F; Hopkins, Claire; Olze, Heidi; Canonica, G Walter; Paggiaro, Pierluigi; Cho, Seong H; Fokkens, Wyt...
Journal:
Lancet
Issue:
Volume 394:Issue 10209(2019)
Page Start:
1638
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Issue 8 (August 2020)

Authors:
Smith, Jaclyn A; Kitt, Michael M; Morice, Alyn H; Birring, Surinder S; McGarvey, Lorcan P; Sher, Mandel R; Li, Yu-Ping; Wu, Wen-Chi; Xu, Zhi Jin; Muccino, David R; Ford, Anthony P; Smith, Jaclyn; McGarvey, Lorcan; Birring, Surinder; Hull, James; Carr, Warner W; Goldsobel, Alan B; Gross, Gary N; H...
Journal:
Lancet
Issue:
Volume 8:Issue 8(2020)
Page Start:
775
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search